# ImpactLife – FDA Inspection, Jan 14, 2020

Source: https://www.keypedia.com/records/fda_inspections/impactlife/bb361849-a210-49c3-ab66-a8e56b399f3f
Source feed: FDA_Inspections

> FDA inspection 1115857 of ImpactLife, January 14, 2020. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1115857
- Company Name: ImpactLife
- Inspection Date: 2020-01-14
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1332592 - 2026-08-14
- FDA Inspection 1047630 - 2018-03-20
- FDA Inspection 955078 - 2015-12-08
- [FDA Inspection 855749 - 2013-11-25](https://www.keypedia.com/records/fda_inspections/impactlife/a0ee83f1-2fbb-400e-8cb2-2b7707acb381)

Company: https://www.keypedia.com/companies/impactlife/b67d007d-626e-469c-987a-2f17e74ea357

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d